1. Izikson, L., Sober, AJ., Mihm, MC., Zembowicz, A. Prevalence of melanoma clinically resembling seborrheic keratosis: analysis of 9204 cases. Arch Dermatol. 2002;138(12):1562-1566.doi:10.1001/archderm.138.12.1562 12472343
Google Scholar | Crossref | Medline2. Longo, C., Moscarella, E., Piana, S et al. Not all lesions with a verrucous surface are seborrheic keratoses. J Am Acad Dermatol. 2014;70(6):e121-123.doi:10.1016/j.jaad.2013.10.042 24831328
Google Scholar | Crossref | Medline3. Hafner, C., Vogt, T. Seborrheic keratosis. J Dtsch Dermatol Ges. 2008;6(8):664-677.doi:10.1111/j.1610-0387.2008.06788.x 18801147
Google Scholar | Crossref | Medline4. Wood, LD., Stucki, JK., Hollenbeak, CS., Miller, JJ. Effectiveness of cryosurgery vs curettage in the treatment of seborrheic keratoses. JAMA Dermatol. 2013;149(1):108-109.doi:10.1001/2013.jamadermatol.275 23324775
Google Scholar | Crossref | Medline5. Ethington, E., Mitri, A., Surprenant, D et al. Patient preferences and comparative outcomes regarding cryosurgery versus Electrodesiccation in the removal of truncal seborrheic keratoses. J Clin Aesthet Dermatol. 2019;12(9):E53-E56.31641420
Google Scholar | Medline6. Kim, YK., Kim, D-Y., Lee, SJ., Chung, WS., Cho, SB. Therapeutic efficacy of long-pulsed 755-nm alexandrite laser for seborrheic keratoses. J Eur Acad Dermatol Venereol. 2014;28(8):1007-1011.doi:10.1111/jdv.12231 23909912
Google Scholar | Crossref | Medline7. Lynam, K., Fahs, F., Daveluy, S. Sudden onset psoriasis causing eruptive seborrheic keratoses. Int J Dermatol. 2020;59(7):e257-e259.doi:10.1111/ijd.14822 32060898
Google Scholar | Crossref | Medline8. Schwartz, RA . Sign of Leser-Trelat. [Review] [129 refs]. 1996;1(1):88-95.
Google Scholar9. Inamadar, AC., Palit, A. Eruptive seborrhoeic keratosis in human immunodeficiency virus infection: a coincidence or the sign of leser-trélat? Br J Dermatol. 2003;149(2):435-436.doi:10.1046/j.1365-2133.2003.05463.x 12932267
Google Scholar | Crossref | Medline10. Williams, JV., Helm, KF., Long, D. Chemotherapy-induced inflammation in seborrheic keratoses mimicking disseminated herpes zoster. J Am Acad Dermatol. 1999;40(4):643-644.doi:10.1016/s0190-9622(99)70455-x 10188692
Google Scholar | Crossref | Medline11. Yamamoto, T . Leser-trelat sign: current observations. Expert Rev Dermatol. 2013;8(5):541-546.doi:10.1586/17469872.2013.835926
Google Scholar | Crossref12. Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, Group, P, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.doi:10.1136/bmj.b2535 19622551
Google Scholar | Crossref | Medline13. Oxford Centre for Evidence-based Medicine – Levels of Evidence. 2020 . https://www.cebm.net/2009/06/oxford-centre-evidence-based-medicine-levels-evidence-march-2009
Google Scholar14. Murad, MH., Sultan, S., Haffar, S., Bazerbachi, F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60-63.doi:10.1136/bmjebm-2017-110853 29420178
Google Scholar | Crossref | Medline15. Wells, G., Shea, B., O’Connell, D et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Google Scholar16. Lindelöf, B., Sigurgeirsson, B., Melander, S. Seborrheic keratoses and cancer. J Am Acad Dermatol. 1992;26(6):947-950.doi:10.1016/0190-9622(92)70139-7 1535080
Google Scholar | Crossref | Medline17. Fink, AM., Filz, D., Krajnik, G., Jurecka, W., Ludwig, H., Steiner, A. Seborrhoeic keratoses in patients with internal malignancies: a case-control study with prospective accrual of patients. J Eur Acad Dermatol Venereol. 2009;23(11):1316-1319.doi:10.1111/j.1468-3083.2009.03163.x 19309432
Google Scholar | Crossref | Medline18. Insuasty, J., Diaz, L., Berbeo, M., Ballesteros, Z., Mantilla, A. RM-043 eruptive seborrheic keratosis (ESK) and its association with gastrointestinal cancer (GIC): a case-control study and meta-analysis. Annals of Oncology. 2016;27(Supplement 2):ii95-ii96.doi:10.1093/annonc/mdw201.40
Google Scholar | Crossref19. Ciardiello, F., Tortora, G. EGFRantagonists in cancer treatment. N Engl J Med. 2008;358(11):1160-1174.doi:10.1056/NEJMra0707704 18337605
Google Scholar | Crossref | Medline | ISI20. Nanney, LB., Magid, M., Stoscheck, CM., King, LE. Comparison of epidermal growth factor binding and receptor distribution in normal human epidermis and epidermal appendages. J Invest Dermatol. 1984;83(5):385-393.doi:10.1111/1523-1747.ep12264708 6092481
Google Scholar | Crossref | Medline21. Ellis, DL., Kafka, SP., Chow, JC et al. Melanoma, growth factors, acanthosis nigricans, the sign of leser-trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med. 1987;317(25):1582-1587.doi:10.1056/NEJM198712173172506 2825016
Google Scholar | Crossref | Medline22. Curry, SS., King, LE. The sign of Leser-Trelat. Report of a case with adenocarcinoma of the duodenum. Arch Dermatol. 1980;116(9):1059-1060.doi:10.1001/archderm.116.9.1059
Google Scholar | Crossref | Medline23. Filipe, MI., Osborn, M., Linehan, J., Sanidas, E., Brito, MJ., Jankowski, J. Expression of transforming growth factor alpha, epidermal growth factor receptor and epidermal growth factor in precursor lesions to gastric carcinoma. Br J Cancer. 1995;71(1):30-36.doi:10.1038/bjc.1995.7 7819044
Google Scholar | Crossref | Medline24. Brauer, J., Happle, R., Gieler, U., Effendy, I. The sign of leser-trelat: fact or myth? J Eur Acad Dermatol Venerol. 1992;1(1):77-80.doi:10.1111/j.1468-3083.1992.tb00703.x
Google Scholar | Crossref25. Ohashi, N., Hidaka, N. Pancreatic carcinoma associated with the leser-trelat sign. Int J Pancreatol. 1997;22(2):155-160.doi:10.1007/BF02787475 9387039
Google Scholar | Crossref | Medline26. Fetil, E., Ozkan, S., Gürler, N., Kuşku, E., Arda, F., Güneş, AT. Recurrent leser-trelat sign associated with two malignancies. Dermatology. 2002;204(3):254-255.doi:10.1159/000057894 12037460
Google Scholar | Crossref | Medline27. Ikari, Y., Ohkura, M., Morita, M., Seki, K., Kubota, Y., Mizoguchi, M. Leser-trelat sign associated with Sezary syndrome. J Dermatol. 1995;22(1):62-67.doi:10.1111/j.1346-8138.1995.tb03343.x 7897028
Google Scholar | Crossref | Medline28. Liddell, K., White, JE., Caldwell, IW. Seborrhoeic keratoses and carcinoma of the large bowel. Three cases exhibiting the sign of Lester-trélat. Br J Dermatol. 1975;92(4):449-452.doi:10.1111/j.1365-2133.1975.tb03107.x 125606
Google Scholar | Crossref | Medline29. Al Ghazal, P., Körber, A., Klode, J., Dissemond, J. Leser-trelat sign and breast cancer. Lancet. 2013;381(9878):1653. doi:10.1016/S0140-6736(12)61257-4 23201213
Google Scholar | Crossref | Medline30. Flugman, SL., McClain, SA., Clark, RA. Transient eruptive seborrheic keratoses associated with erythrodermic psoriasis and erythrodermic drug eruption: report of two cases. J Am Acad Dermatol. 2001;45(6 Suppl):S212-S214.doi:10.1067/mjd.2001.103641 11712062
Google Scholar | Crossref | Medline31. Chadwick, PW., Heymann, WR. Eruptive seborrheic keratoses secondary to telaprevir-related dermatitis. Cutis. 2016;98(2):E20-21.
Google Scholar | Medline32. Kechijian, P., Sadick, NS., Mariglio, J., Schulman, P. Cytarabine-induced inflammation in the seborrheic keratoses of leser-trelat. Ann Intern Med. 1979;91(6):868-869.doi:10.7326/0003-4819-91-6-868 293142
Google Scholar | Crossref | Medline33. Patton, T., Zirwas, M., Nieland-Fisher, N., Jukic, D. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of leser-trelat. J Drugs Dermatol. 2004;3(5):565-566.15552612
Google Scholar | Medline34. Aamir, S., Ullah, Z., Iqbal, Z., Khan, AA., Yaqub, F., Malik, K. Cutaneous manifestations of interferon alfa and ribavirin for hepatitis C. J Pak Assoc Dermatol. 2008;18:14-20.
Google Scholar35. Kowalzick, L., Truhm, B., Theilig, M., Eickenscheidt, L., Neuser, H. Pseudo-sign of leser-trelat: acute inflammation of seborrheic keratoses during chemotherapy with docetaxel. [German]. 2013;10:397-399.
Google Scholar